Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Zimny

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Nuclear Medicine Communications|November 25, 2003
Radioiodine therapy in patients with hyperthyroid disorder: standard versus dosimetric activity applicationP Reinartz, M Zimny, W Schaefer, et al.
Nuclear Medicine Communications|December 23, 1998
Positron emission tomography with 18F-FDG to detect residual disease after therapy for malignant lymphomaU Cremerius, U Fabry, J Neuerburg, et al.
Nuklearmedizin. Nuclear Medicine|April 25, 2012
Risk of malignancy in follicular thyroid neoplasm: predictive value of thyrotropinM Zimny, I Selkinski, S Blasius, et al.
European Urology|June 5, 1998
Is prostate-specific antigen a reliable marker of bone metastasis in patients with newly diagnosed cancer of the prostate?J M Wolff, M Zimny, H Borchers, et al.
Zeitschrift Fur Kardiologie|September 1, 1993
[Improved left ventricular ejection fraction directly after transluminal coronary angioplasty]H Klepzig, A Hartmann, M Rieger, et al.
European Journal of Nuclear Medicine|December 6, 2000
Does thyroid stunning exist? A model with benign thyroid diseaseO Sabri, M Zimny, M Schreckenberger, et al.
The Journal of Clinical Endocrinology and Metabolism|April 13, 1999
Success rate of radioiodine therapy in Graves' disease: the influence of thyrostatic medicationO Sabri, M Zimny, G Schulz, et al.
Nuklearmedizin. Nuclear Medicine|February 13, 1999
[Clinical value of FDG PET for therapy monitoring of malignant lymphoma--results of a retrospective study in 72 patients]U Cremerius, U Fabry, U Kröll, et al.
Gynecologic Oncology|October 19, 2001
2-[Fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography in the diagnosis of recurrent ovarian cancerM Zimny, W Siggelkow, W Schröder, et al.
Nuklearmedizin. Nuclear Medicine|February 13, 1999
[Radioiodine therapy in veterinary medicine: treatment of hyperthyroidism in a cat]P Reinartz, O Sabri, S Kinzel, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Nuclear Medicine Communications|November 25, 2003
Radioiodine therapy in patients with hyperthyroid disorder: standard versus dosimetric activity applicationP Reinartz, M Zimny, W Schaefer, et al.
Nuclear Medicine Communications|December 23, 1998
Positron emission tomography with 18F-FDG to detect residual disease after therapy for malignant lymphomaU Cremerius, U Fabry, J Neuerburg, et al.
Nuklearmedizin. Nuclear Medicine|April 25, 2012
Risk of malignancy in follicular thyroid neoplasm: predictive value of thyrotropinM Zimny, I Selkinski, S Blasius, et al.
European Urology|June 5, 1998
Is prostate-specific antigen a reliable marker of bone metastasis in patients with newly diagnosed cancer of the prostate?J M Wolff, M Zimny, H Borchers, et al.
Zeitschrift Fur Kardiologie|September 1, 1993
[Improved left ventricular ejection fraction directly after transluminal coronary angioplasty]H Klepzig, A Hartmann, M Rieger, et al.
European Journal of Nuclear Medicine|December 6, 2000
Does thyroid stunning exist? A model with benign thyroid diseaseO Sabri, M Zimny, M Schreckenberger, et al.
The Journal of Clinical Endocrinology and Metabolism|April 13, 1999
Success rate of radioiodine therapy in Graves' disease: the influence of thyrostatic medicationO Sabri, M Zimny, G Schulz, et al.
Nuklearmedizin. Nuclear Medicine|February 13, 1999
[Clinical value of FDG PET for therapy monitoring of malignant lymphoma--results of a retrospective study in 72 patients]U Cremerius, U Fabry, U Kröll, et al.
Gynecologic Oncology|October 19, 2001
2-[Fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography in the diagnosis of recurrent ovarian cancerM Zimny, W Siggelkow, W Schröder, et al.
Nuklearmedizin. Nuclear Medicine|February 13, 1999
[Radioiodine therapy in veterinary medicine: treatment of hyperthyroidism in a cat]P Reinartz, O Sabri, S Kinzel, et al.
Pageof 6